Health Canada drug identification number

DIN 02487500 — CABAZITAXEL FOR INJECTION 60 MG

CABAZITAXEL FOR INJECTION is a solution of Cabazitaxel marketed by SANDOZ CANADA INCORPORATED. The full Cabazitaxel monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02487500
Brand name
CABAZITAXEL FOR INJECTION
Active ingredient
Cabazitaxel
Strength
60 MG
Dosage form
SOLUTION
Route
INTRAVENOUS
Manufacturer
SANDOZ CANADA INCORPORATED
Health Canada status
MARKETED
Drug class
Taxane antineoplastic agent (microtubule inhibitor)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Cabazitaxel products

DINBrandStrengthFormManufacturerStatus
02495635 CABAZITAXEL FOR INJECTION 40 MG SOLUTION DR REDDY'S LABORATORIES LTD MARKETED
02487497 CABAZITAXEL FOR INJECTION 45 MG SOLUTION SANDOZ CANADA INCORPORATED MARKETED
02553783 CABAZITAXEL FOR INJECTION 45 MG SOLUTION FORMATIVE PHARMA INC. MARKETED
02553791 CABAZITAXEL FOR INJECTION 60 MG SOLUTION FORMATIVE PHARMA INC. MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.